Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
European Heart Journal (2019) Vol. 41, Iss. 1, pp. 111-188
Open Access | Times Cited: 6897

Showing 1-25 of 6897 citing articles:

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4289
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean‐Philippe Collet, Hölger Thiele, Emanuele Barbato, et al.
European Heart Journal (2020) Vol. 42, Iss. 14, pp. 1289-1367
Open Access | Times Cited: 4203
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Alec Vahanian, Friedhelm Beyersdorf, Fabien Praz, et al.
European Heart Journal (2021) Vol. 43, Iss. 7, pp. 561-632
Open Access | Times Cited: 3724
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger, Claudio Borghi, Fadi J. Charchar, et al.
Hypertension (2020) Vol. 75, Iss. 6, pp. 1334-1357
Open Access | Times Cited: 3128
2023 ESC Guidelines for the management of acute coronary syndromes
Robert A. Byrne, Xavier Rosselló, J J Coughlan, et al.
European Heart Journal (2023) Vol. 44, Iss. 38, pp. 3720-3826
Open Access | Times Cited: 1904
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1904
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal (2022) Vol. 43, Iss. 41, pp. 4229-4361
Open Access | Times Cited: 1579
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1554
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
Antonio Pelliccia, Sanjay Sharma, Sabiha Gati, et al.
European Heart Journal (2020) Vol. 42, Iss. 1, pp. 17-96
Open Access | Times Cited: 1282
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 16, pp. 1507-1519
Open Access | Times Cited: 1135
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Borén, M. John Chapman, Ronald M. Krauss, et al.
European Heart Journal (2020) Vol. 41, Iss. 24, pp. 2313-2330
Open Access | Times Cited: 1125
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
Steven H J Hageman, Lisa Pennells, Francisco Ojeda, et al.
European Heart Journal (2021) Vol. 42, Iss. 25, pp. 2439-2454
Open Access | Times Cited: 963
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Weimar Kunz Sebba Barroso, Cibele Isaac Saad Rodrigues, Luiz Aparecido Bortolotto, et al.
Arquivos Brasileiros de Cardiologia (2021) Vol. 116, Iss. 3, pp. 516-658
Open Access | Times Cited: 786
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
Florian Kronenberg, Samia Mora, Erik S.G. Stroes, et al.
European Heart Journal (2022) Vol. 43, Iss. 39, pp. 3925-3946
Open Access | Times Cited: 671
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Tom G. Richardson, Eleanor Sanderson, Tom Palmer, et al.
PLoS Medicine (2020) Vol. 17, Iss. 3, pp. e1003062-e1003062
Open Access | Times Cited: 660
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 6, pp. 497-509
Open Access | Times Cited: 651
2020 International Society of Hypertension global hypertension practice guidelines
Thomas Unger, Claudio Borghi, Fadi J. Charchar, et al.
Journal of Hypertension (2020) Vol. 38, Iss. 6, pp. 982-1004
Open Access | Times Cited: 643
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong, Ziyang Cui, Xiao-Fu Huang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 577
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
Kausik K. Ray, Bart Molemans, W. Marieke Schoonen, et al.
European Journal of Preventive Cardiology (2020) Vol. 28, Iss. 11, pp. 1279-1289
Open Access | Times Cited: 547
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg, Chris J. Packard, M. John Chapman, et al.
European Heart Journal (2021) Vol. 42, Iss. 47, pp. 4791-4806
Open Access | Times Cited: 536
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Friedhelm Beyersdorf, Alec Vahanian, Milan Milojevic, et al.
European Journal of Cardio-Thoracic Surgery (2021) Vol. 60, Iss. 4, pp. 727-800
Open Access | Times Cited: 492
Arterial hypertension in adults. Clinical guidelines 2020
Zhanna Kobalava, А. О. Конради, С. В. Недогода, et al.
Russian Journal of Cardiology (2020) Vol. 25, Iss. 3, pp. 3786-3786
Open Access | Times Cited: 483
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
Gissette Reyes‐Soffer, Henry N. Ginsberg, Lars Berglund, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 42, Iss. 1
Open Access | Times Cited: 469
2024 ESC Guidelines for the management of chronic coronary syndromes
Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas, et al.
European Heart Journal (2024) Vol. 45, Iss. 36, pp. 3415-3537
Open Access | Times Cited: 456
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
Javier Delgado‐Lista, Juan F. Alcalá‐Díaz, José D. Torres‐Peña, et al.
The Lancet (2022) Vol. 399, Iss. 10338, pp. 1876-1885
Open Access | Times Cited: 383
Page 1 - Next Page

Scroll to top